Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

J Mercier Ythier1

  • 1CRED, université de Paris Panthéon-Assas, 12, place du Panthéon, 75005 Paris, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|November 19, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

An international plasma market exists, supplying raw materials for pharmaceuticals. This globalized market presents economic opportunities and challenges, with contract fractionation offering a potential solution.

Area of Science:

  • Health Economics
  • Pharmaceutical Industry
  • Blood Product Regulation

Background:

  • Voluntary blood donation is the norm for transfusions, emphasizing safety and cost-effectiveness.
  • The principle of non-commercialization of body parts has exceptions within the blood product economy.
  • A significant international plasma market operates, supplying raw materials for pharmaceutical production.

Purpose of the Study:

  • To analyze the economic dynamics of the international plasma market.
  • To examine the increasing globalization and scale of this market.
  • To propose solutions for the issues arising from plasma market evolution.

Main Methods:

  • Economic analysis of the blood product market.
  • Review of trends in the global plasma market.
Keywords:
Blood protein productsContract fractionationContrats de fractionnementDon de sangFree blood donationGratuitéMédicaments dérivés du sangPlasmapheresisPlasmaphérèse

Related Experiment Videos

  • Exploration of contract fractionation as an economic model.

    • Main Results:

    • A robust international plasma market exists, distinct from donation for transfusion.
    • This market has become increasingly massive and globalized in recent years.
    • Contract fractionation is identified as a potentially viable economic strategy.

    Conclusions:

    • The international plasma market represents a significant exception to non-commercialization principles.
    • Addressing the challenges of this market requires careful consideration of economic and ethical factors.
    • Contract fractionation offers a promising avenue for economic development within the plasma industry.